Thryv Therapeutics, Inc. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   Describe Health-Related Quality of Life and Measure Disease Burden…Describe Health-Related Quality of Life and Measure Disease Burden · Long QT Syndrome Types (LQTS) 2 and 3

   Enrollment closed, study ongoing

   Thryv Therapeutics, Inc.·Not specified· NCT07075445· Registry history of NCT07075445 on ClinicalTrials.gov (opens the registry)

   Updated Oct 8, 2026

2. Minor

   Wave II · THRV-1268 · Long QT Syndrome Type 2 (LQTS2) and Type…Wave II · THRV-1268 · Long QT Syndrome Type 2 (LQTS2) and Type 3 (LQTS3)

   Enrollment increased: 64 → 84 participants

   Thryv Therapeutics, Inc.·Phase 2/3· NCT07277582· Registry history of NCT07277582 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.